Cargando…

A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 Therapy

Metaplastic breast cancer is a rare and often chemo-refractory subtype of breast cancer with poor prognosis and limited treatment options. Recent studies have reported overexpression of programmed death ligand 1 (PD-L1) in metaplastic breast cancers, and there are several reports of anti-PD-1/L1 bei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Isaac, Rajamanickam, Venkatesh, Bernard, Brady, Chun, Brie, Wu, Yaping, Martel, Maritza, Sun, Zhaoyu, Redmond, William L., Sanchez, Katherine, Basho, Reva, McArthur, Heather, Page, David B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217650/ https://www.ncbi.nlm.nih.gov/pubmed/34168978 http://dx.doi.org/10.3389/fonc.2021.635237

Ejemplares similares

A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer
por: Page, David B., et al.
Publicado: (2023)

Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer
por: Sanchez, Katherine, et al.
Publicado: (2021)

Optimizing (neo)adjuvant treatment of HER2-positive breast cancer
por: Basho, Reva K., et al.
Publicado: (2018)

Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer
por: Chun, Brie, et al.
Publicado: (2022)

Genetic Testing in Metastatic Breast Cancer in the USA: A Podcast
por: Basho, Reva, et al.
Publicado: (2023)

Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer
por: Gorshein, Elan, et al.
Publicado: (2021)

Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor
por: Curti, Brendan D, et al.
Publicado: (2021)

Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancers
por: Sun, Zhaoyu, et al.
Publicado: (2021)

Patterns of Care and Survival of Metastatic Metaplastic Breast Cancer Patients
por: Youssef, Irini, et al.
Publicado: (2020)

Metastatic Metaplastic Breast Cancer Successfully Treated with Adriamycin and Cisplatin
por: Hayashino, Kenta, et al.
Publicado: (2022)

Metaplastic breast carcinomas – analysis of prognostic factors in a case series
por: Nowara, Elżbieta, et al.
Publicado: (2014)

Metaplastic changes in the epithelium of radicular cysts: A series of 711 cases
por: Tsesis, Igor, et al.
Publicado: (2016)

Clinicopathological Examination of Metaplastic Spindle Cell Carcinoma of the Breast: Case Series
por: Ishizuka, Yumiko, et al.
Publicado: (2021)

Neurogranin Regulates Metaplasticity
por: Zhong, Ling, et al.
Publicado: (2020)

Squamous Cell Differentiation in Metastatic Papillary Thyroid Carcinoma: Metaplastic Reversion or Progression?
por: Handra-Luca, Adriana
Publicado: (2018)

Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma
por: Lien, Huang-Chun, et al.
Publicado: (2023)

Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature
por: Papatheodoridi, Alkistis, et al.
Publicado: (2023)

PD-1 and ICOS coexpression identifies tumor-reactive CD4(+) T cells in human solid tumors
por: Duhen, Rebekka, et al.
Publicado: (2022)

Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy Combination
por: Al Sayed, Adher D., et al.
Publicado: (2019)

Challenges to diagnose metaplastic carcinoma of the breast through cytologic methods: an eight-case series
por: Lale, Seema, et al.
Publicado: (2011)

Sonographic and pathological features of metaplastic squamous cell carcinoma of the breast: a case series
por: Ye, Xiao-Jian, et al.
Publicado: (2021)

The metaplastic mosaic of Barrett’s oesophagus
por: Biswas, Sujata, et al.
Publicado: (2018)

Synaptic Plasticity, Metaplasticity and Depression
por: Vose, Linnea R., et al.
Publicado: (2017)

Aromatase inhibitor strategies in metastatic breast cancer
por: McArthur, Heather L, et al.
Publicado: (2010)

Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1
por: Kalaw, Emarene, et al.
Publicado: (2020)

Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer
por: Page, David B., et al.
Publicado: (2019)

Case report: Metastatic metaplastic breast cancer with choriocarinomatous features: Targeting the choriocarcinoma component for cure
por: Mehta, Krisha K., et al.
Publicado: (2023)

COVID-19 in cancer patients: risk, clinical features, and management
por: Liu, Cuiwei, et al.
Publicado: (2020)

Metaplastic Breast Cancer: To Radiate or Not to Radiate?
por: Tseng, Warren H., et al.
Publicado: (2010)

Treatment Options for Metaplastic Breast Cancer
por: Shah, Dhruvil R., et al.
Publicado: (2012)

Structural Plasticity Can Produce Metaplasticity
por: Kalantzis, Georgios, et al.
Publicado: (2009)

Totally Ossified Metaplastic Spinal Meningioma
por: Ju, Chang Il, et al.
Publicado: (2013)

Metaplastic Thymoma: Report of 4 Cases
por: Kang, Guhyun, et al.
Publicado: (2012)

Models of Metaplasticity: A Review of Concepts
por: Yger, Pierre, et al.
Publicado: (2015)

Spinal metaplasticity in respiratory motor control
por: Fields, Daryl P., et al.
Publicado: (2015)

Metaplastic carcinoma of the breast: an immunohistochemical study
por: Altaf, Fadwa J, et al.
Publicado: (2014)

Metaplastic breast cancer with chondroid differentiation
por: Myint, Zin W., et al.
Publicado: (2015)

Human Metaplastic Breast Carcinoma and Decorin
por: Boström, Pia, et al.
Publicado: (2017)

Metaplastic Meningioma Overspreading the Cerebral Convexity
por: Choi, Yun-Hyeok, et al.
Publicado: (2018)

Optimal structure of metaplasticity for adaptive learning
por: Khorsand, Peyman, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0s1ur9g26hb6tde9po7faoi1sb